Chronic elevation of brain-derived neurotrophic factor by ampakines - Wikidata - wikimedia - TriplyDB

Chronic elevation of brain-derived neurotrophic factor by ampakines

Chronic elevation of brain-derived neurotrophic factor by ampakines

http://www.wikidata.org/entity/Q28191459

about

Brain-derived neurotrophic factor: role in depression and suicide Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation Fragile X syndrome and targeted treatment trials.Toxic stress, inflammation and symptomatology of chronic complications in diabetes Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices AMPAKINE enhancement of social interaction in the BTBR mouse model of autism Bipolar disorder: candidate drug targets.Transprocessing: a proposed neurobiological mechanism of psychotherapeutic processing.Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and Ampakines Effects of non-pharmacological or pharmacological interventions on cognition and brain plasticity of aging individuals.BDNF upregulation rescues synaptic plasticity in middle-aged ovariectomized rats.Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor The expanding role of BDNF: a therapeutic target for Alzheimer's disease?Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets Chronic Ampakine Treatments Stimulate Dendritic Growth and Promote Learning in Middle-Aged Rats The substrates of memory: defects, treatments, and enhancement.The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases Potential therapeutic approaches for Angelman syndrome.Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network Post-anesthesia AMPA receptor potentiation prevents anesthesia-induced learning and synaptic deficits.Synaptic regulation of affective behaviors; role of BDNF Adaptations in AMPA receptor transmission in the nucleus accumbens contributing to incubation of cocaine craving.Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.AMPA receptor positive allosteric modulators: a patent review.Neurotrophic factors in development and regulation of respiratory control.Neurotrophin strategies for neuroprotection: are they sufficient?Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor.Multiple faces of BDNF in cocaine addiction.Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasis.Synthesis, crystal structure and anti-fatigue effects of some benzamide derivatives.Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.

P2860

Q24647110-F4FCF164-5810-4A38-BF9B-B1D14612008F Q24652009-ED44C2E9-1FC2-4E19-A8AF-70167B72174F Q24653485-1F169B8A-D65B-45BA-859A-F237180DCAB2 Q26865162-0740B41F-7528-4ECF-9B71-4C985B4E9655 Q27011633-79BEAAA8-FBC7-498F-8A19-712853BC575F Q27023257-19EEE582-13AD-4963-9238-1A3915261474 Q28241512-757A9F37-0F11-44A5-A536-BDE102F8848F Q28388762-471FADEC-9CB8-4EA9-AD41-69D2F01A2F07 Q28751133-C002B128-34F8-41E9-A7D4-90EBFB20E174 Q30423644-C5C52DEA-7090-411E-B262-1B1859E6BA42 Q30486668-692385B9-9EAD-4471-B9A7-187DE07EC2DD Q30977943-230A1EAB-DDF7-4326-9010-651F81EBBD06 Q33705003-91569DEE-FFE1-4153-A88F-3641BE7004DC Q34118141-E8F9A3C2-E9FE-4889-9FE5-9397FAE89974 Q34300194-6D645695-DAB0-4326-B079-D280BC20D8C0 Q34459323-BBB3A4F6-28FF-4FCE-AC01-3C6D639CCF04 Q34579324-50BE858C-933C-49D5-86C0-AC03CBB4A535 Q35008236-ED0BEAA8-2A97-457F-9C0B-4BA76EE7968C Q36325596-D8427DD7-15A3-49F1-BF59-4EAE63DAD88E Q36401907-C9CE915F-2D1A-4440-92F3-6E1B98FAD164 Q36534364-2ADEED41-80D5-484E-8D46-B28FC23EE77D Q36718516-9D33C254-76A5-460C-BC85-8B2796CD403F Q36740187-D49BEE80-4F11-4A81-8313-987C956F8DED Q36992786-C09EE2E0-36E9-4DA1-B90F-6DA8D344BA67 Q37013319-4B849563-0328-414F-BA73-FB53A22C4F35 Q37143117-4596BBCA-6EE3-44F0-824B-795A7288D499 Q37148672-58EB551C-E06A-4449-89F1-F5F99AF4E26F Q37260818-7B2CC80C-CAFE-4961-AC13-450C63F6E7E2 Q37302923-8F1ACEE7-A3B6-4981-8139-4A1AAEA0DC03 Q37333137-2B6F02D6-E3A9-4149-B473-1E2342B7BEAB Q37379871-63C79477-6791-4524-821E-F8AA52DA0A87 Q38019570-B978D276-C30F-49E0-B4C5-009D76C606F5 Q38081162-6A217074-25FC-41D8-ACA8-DB9FB128284C Q38125146-7FE01840-81AE-4729-AAD3-EB26D451B3AB Q38194485-0BC3586D-A70E-4600-96FE-1C341236739E Q38260556-25441B59-2799-4CAC-8125-E3837267E87E Q38275624-02B8615B-66D2-4798-9189-A56C22CB7AEB Q38406750-965819DE-5650-4AFF-B8BD-BEFC9B49A124 Q39268965-0D83867B-D311-4DC2-A46D-B148241CF5C9 Q39557334-2CB99B9D-48B9-4EDD-9F98-6A9283A35BF1

P2860

Chronic elevation of brain-derived neurotrophic factor by ampakines

http://www.wikidata.org/entity/Q28191459

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Chronic elevation of brain-derived neurotrophic factor by ampakines

@ast

Chronic elevation of brain-derived neurotrophic factor by ampakines

@en

Chronic elevation of brain-derived neurotrophic factor by ampakines

@nl

type

label

Chronic elevation of brain-derived neurotrophic factor by ampakines

@ast

Chronic elevation of brain-derived neurotrophic factor by ampakines

@en

Chronic elevation of brain-derived neurotrophic factor by ampakines

@nl

prefLabel

Chronic elevation of brain-derived neurotrophic factor by ampakines

@ast

Chronic elevation of brain-derived neurotrophic factor by ampakines

@en

Chronic elevation of brain-derived neurotrophic factor by ampakines

@nl

P1433

Q28191459-282D17E8-143E-4263-B54E-EED4312C06C5

P1476

Q28191459-0E41A0EC-5C5B-43B7-871F-72654BAD0B17

P2093

Q28191459-0318C79C-7836-467C-8670-F395FDFD5852

Q28191459-09ABC8AF-F087-4A09-AFCD-B1F85EF8DEE7

Q28191459-710FB8C1-E3EE-45BD-9AC1-9D24BC50C9C3

Q28191459-84D34FCC-ECBA-4802-A3BC-681DC8D6AC9F

Q28191459-D04006CA-119B-41F0-B092-B93E52FABBC5

Q28191459-E6A63841-3326-422B-BB5B-E803C4862EF2

P304

Q28191459-3CC04DBA-7620-43E5-80BA-F0D93A6DB07F

P31

Q28191459-AF455BC3-FC26-480F-B331-5439435D8B4B

P356

Q28191459-393051B0-A387-4F0F-8C99-06DA4A9E2041

P407

Q28191459-761C3C5A-64DB-4BDA-A7F4-46475FF7D8D7

P433

Q28191459-FCC906D6-DA7D-439A-8D24-3AD0BAA501A6

P478

Q28191459-EA0DE495-B876-4E49-B5A5-3C71B90CA24D

P577

Q28191459-02568F8D-95AF-4406-9786-5D05DE879111

P5875

Q28191459-9FB38626-1E9B-4162-8F82-DE4B77E66CA1

P698

Q28191459-8455110F-6EE9-4507-B875-2F579E1E5FF2

P921

Q28191459-A4C39F05-ABC4-4B4D-84F4-ECDBEEF80311

P356

JPET.103.053694

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Chronic elevation of brain-derived neurotrophic factor by ampakines

@en

P2093

Christine M Gall

http://www.w3.org/2001/XMLSchema#string

Gary Lynch

http://www.w3.org/2001/XMLSchema#string

Giang S Truong

http://www.w3.org/2001/XMLSchema#string

Julie C Lauterborn

http://www.w3.org/2001/XMLSchema#string

Michel Baudry

http://www.w3.org/2001/XMLSchema#string

Xiaoning Bi

http://www.w3.org/2001/XMLSchema#string

P304

297-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.103.053694

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10633020

http://www.w3.org/2001/XMLSchema#string

P698

12893840

http://www.w3.org/2001/XMLSchema#string

P921